AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32492920 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual Lymph Drainage (MLD)
Number of subjects: 52
Study 32492920 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal Massage (AM)
Number of subjects: 52
Study 32492920 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical Stimulation (ES)
Number of subjects: 52
Study 35620984 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter-directed thrombolysis (CDT)
Number of subjects: 23
Study 35620984 — intervention group
Group type: COMPARATOR
Intervention: Standard anticoagulation
Number of subjects: 23
Study 33894838 — intervention group
Group type: EXPERIMENTAL
Intervention: Cagrilintide 1.2 mg with semaglutide 2.4 mg
Number of subjects: 96
Study 33894838 — intervention group
Group type: EXPERIMENTAL
Intervention: Cagrilintide 2.4 mg with semaglutide 2.4 mg
Number of subjects: 96
Study 33894838 — intervention group
Group type: EXPERIMENTAL
Intervention: Cagrilintide 4.5 mg with semaglutide 2.4 mg
Number of subjects: 96
Study 33894838 — intervention group
Group type: COMPARATOR
Intervention: Cagrilintide (0.16–4.5 mg) and semaglutide 2.4 mg
Number of subjects: 96
Study 32363926 — intervention group
Group type: EXPERIMENTAL
Intervention: Tropicana 50 (TRP50)
Number of subjects: 10
Study 32363926 — intervention group
Group type: EXPERIMENTAL
Intervention: Kroger low-calorie OJ (KLCO)
Number of subjects: 10
Study 32363926 — intervention group
Group type: EXPERIMENTAL
Intervention: Crystal light lemonade beverage (CLLB)
Number of subjects: 10
Study 34353065 — intervention group
Group type: EXPERIMENTAL
Intervention: Floating needle therapy combined with acupoint embedding
Number of subjects: 64
Study 34353065 — intervention group
Group type: COMPARATOR
Intervention: Midodrine combined with Kegel training
Number of subjects: 64
Study 35241140 — intervention group
Group type: EXPERIMENTAL
Intervention: m-health-based exercise (via guidance plus education)
Number of subjects: 40
Study 35241140 — intervention group
Group type: COMPARATOR
Intervention: m-health-based exercise (via guidance)
Number of subjects: 40
Study 33227510 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-guided internet-delivered pain management program (PMP)
Number of subjects: 490
Study 33227510 — intervention group
Group type: EXPERIMENTAL
Intervention: Optional-guided internet-delivered pain management program (PMP)
Number of subjects: 490
Study 33227510 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician-guided internet-delivered pain management program (PMP)
Number of subjects: 490
Study 33969958 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 sets of resistance training (10‐SET)
Number of subjects: 15
Study 33969958 — intervention group
Group type: COMPARATOR
Intervention: 5 sets of resistance training (5‐SET)
Number of subjects: 15
Study 33907903 — intervention group
Group type: EXPERIMENTAL
Intervention: Food Assistance Programs (FAPs)
Number of subjects: 329
Study 33907903 — intervention group
Group type: EXPERIMENTAL
Intervention: Informal food resources
Number of subjects: 329
Study 35894422 — intervention group
Group type: EXPERIMENTAL
Intervention: Modifications in the school environment (painting of hopscotch and school courts, provision of sports equipment)
Number of subjects: 975
Study 35894422 — intervention group
Group type: COMPARATOR
Intervention: Control group (no modifications)
Number of subjects: 975
Study 32456097 — intervention group
Group type: EXPERIMENTAL
Intervention: Feelbreathe® device (FB group)
Number of subjects: 16
Study 32456097 — intervention group
Group type: EXPERIMENTAL
Intervention: Oronasal breathing without FB (ONB group)
Number of subjects: 16
Study 32456097 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 16
Study 34052372 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP)
Number of subjects: 38
Study 34052372 — intervention group
Group type: COMPARATOR
Intervention: Control (no PRP)
Number of subjects: 38
Study 33031557 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Fasting 70% (IF70)
Number of subjects: 76
Study 33031557 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Fasting 70% (IF70) and Intermittent Fasting 100% (IF100)
Number of subjects: 76
Study 33031557 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Fasting groups (IF70 and IF100)
Number of subjects: 76
Study 33031557 — intervention group
Group type: COMPARATOR
Intervention: Caloric Restriction 70% (CR70)
Number of subjects: 76
Study 33031557 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Fasting 100% (IF100)
Number of subjects: 76
Study 35148742 — intervention group
Group type: EXPERIMENTAL
Intervention: Matched care physiotherapy intervention
Number of subjects: 9
Study 35148742 — intervention group
Group type: EXPERIMENTAL
Intervention: Illness Perceptions (IPs)
Number of subjects: 9
Study 35148742 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal control
Number of subjects: 9
Study 32543422 — intervention group
Group type: EXPERIMENTAL
Intervention: Home yard-size (measured in hectares)
Number of subjects: 531
Study 32543422 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous year MVPA (adjusted for direct-effect association)
Number of subjects: 531
Study 35855557 — intervention group
Group type: EXPERIMENTAL
Intervention: Vorapaxar
Number of subjects: 26449
Study 35855557 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26449
Study 33651908 — intervention group
Group type: EXPERIMENTAL
Intervention: High ligation (HL)
Number of subjects: 95
Study 33651908 — intervention group
Group type: EXPERIMENTAL
Intervention: Low ligation (LL)
Number of subjects: 95
Study 32685097 — intervention group
Group type: EXPERIMENTAL
Intervention: Mulberry milk (10 g)
Number of subjects: 46
Study 32685097 — intervention group
Group type: COMPARATOR
Intervention: Placebo milk (50 mL)
Number of subjects: 46
Study 34983438 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver reported family functioning
Number of subjects: 65
Study 34983438 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver employment status
Number of subjects: 65
Study 34983438 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver hopefulness
Number of subjects: 65
Study 34983438 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver burden measurement using Burden Assessment Scale
Number of subjects: 65
Study 34006923 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat dietary intervention
Number of subjects: 48835
Study 34006923 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (control)
Number of subjects: 48835
Study 37199879 — intervention group
Group type: EXPERIMENTAL
Intervention: High adherence (MMAS-8 score of 8)
Number of subjects: 1214
Study 37199879 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in MMAS-8 score by 2 points among participants with baseline score ≤ 6
Number of subjects: 1214
Study 34766214 — intervention group
Group type: EXPERIMENTAL
Intervention: mini percutaneous nephrolithotomy (mPNL)
Number of subjects: 120
Study 34766214 — intervention group
Group type: COMPARATOR
Intervention: retrograde intrarenal surgery (RIRS)
Number of subjects: 120
Study 32592589 — intervention group
Group type: EXPERIMENTAL
Intervention: haloperidol
Number of subjects: 1000
Study 32592589 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1000
Study 35191639 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral lumbar ultrasound-guided erector spinae plane block (ESPB) with 0.375% ropivacaine 40 mL
Number of subjects: 60
Study 35191639 — intervention group
Group type: COMPARATOR
Intervention: Local infiltration with 0.375% ropivacaine 40 mL
Number of subjects: 60
Study 33710764 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus chemotherapy (combination therapy group)
Number of subjects: 71
Study 33710764 — intervention group
Group type: COMPARATOR
Intervention: Pembrolizumab monotherapy (monotherapy group)
Number of subjects: 71
Study 33710764 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with PD-L1 TPS ≥50% in combination therapy group
Number of subjects: 71
Study 33710764 — intervention group
Group type: COMPARATOR
Intervention: Patients with PD-L1 TPS ≥50% in monotherapy group
Number of subjects: 71
Study 33072215 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooperative flipped learning method
Number of subjects: 61
Study 33072215 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual flipped learning method
Number of subjects: 61
Study 33072215 — intervention group
Group type: COMPARATOR
Intervention: Conventional method (Control)
Number of subjects: 61
Study 33947416 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration training (WBV) on a vibration platform (Galileo) at varying frequencies (5–26 Hz)
Number of subjects: 48
Study 33947416 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration training (WBV)
Number of subjects: 48
Study 33947416 — intervention group
Group type: COMPARATOR
Intervention: Conventional balance training (BAL)
Number of subjects: 48
Study 32268601 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain Breaks videos (10 min in duration) shared through a WhatsApp group
Number of subjects: 70
Study 32268601 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 70
Study 35964870 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase-specific brain stimulation targeting mu rhythm (0°, 90°, 180°, 270°) with TMS
Number of subjects: 20
Study 35964870 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase-specific brain stimulation targeting beta rhythm (0°, 90°, 180°, 270°) with TMS
Number of subjects: 20
Study 35964870 — intervention group
Group type: EXPERIMENTAL
Intervention: Mu power
Number of subjects: 20
Study 35964870 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta power
Number of subjects: 20
Study 32305995 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (Lactobacillus rhamnosus, LGG® and Bifidobacterium animalis spp. lactis, BB‐12®) for 6 months
Number of subjects: 186
Study 32305995 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 186
Study 32305995 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 186
Study 32157582 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise and PBM active group (n=16)
Number of subjects: 34
Study 32157582 — intervention group
Group type: COMPARATOR
Intervention: Exercise and PBM placebo group (n=17)
Number of subjects: 34
Study 33002672 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab (IVB)
Number of subjects: 0
Study 33002672 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab (IVR)
Number of subjects: 0
Study 33002672 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept (IVA)
Number of subjects: 0
Study 33028236 — intervention group
Group type: EXPERIMENTAL
Intervention: MS Spasticity: Take Control (STC) program
Number of subjects: 220
Study 33028236 — intervention group
Group type: COMPARATOR
Intervention: Control program (NMSS brochure)
Number of subjects: 220
Study 32883164 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guided (USG) cannulation
Number of subjects: 32
Study 32883164 — intervention group
Group type: COMPARATOR
Intervention: Standard cannulation (no USG)
Number of subjects: 32
Study 36148625 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (TCM) powder
Number of subjects: 80
Study 36148625 — intervention group
Group type: COMPARATOR
Intervention: Gauze padding containing furacilin
Number of subjects: 80
Study 32614733 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomechanical risk factors evaluation
Number of subjects: 20
Study 32614733 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergonomic interventions
Number of subjects: 20
Study 33647122 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% deet (Bushman™)
Number of subjects: 0
Study 33647122 — intervention group
Group type: COMPARATOR
Intervention: 31.2% metofluthrin (OFF!® Clip‐On™)
Number of subjects: 0
Study 34326294 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater occipital nerve stimulation
Number of subjects: 40
Study 34326294 — intervention group
Group type: EXPERIMENTAL
Intervention: Trigeminal stimulation
Number of subjects: 40
Study 34326294 — intervention group
Group type: EXPERIMENTAL
Intervention: GON stimulation with capsaicin
Number of subjects: 40
Study 34326294 — intervention group
Group type: EXPERIMENTAL
Intervention: Trigeminal stimulation on V1
Number of subjects: 40
Study 33762145 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose coaching with ECHO
Number of subjects: 48
Study 33762145 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose coaching without ECHO
Number of subjects: 48
Study 33762145 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose coaching with ECHO
Number of subjects: 48
Study 33762145 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose coaching without ECHO
Number of subjects: 48
Study 34757700 — intervention group
Group type: EXPERIMENTAL
Intervention: Persian metabolic diet (PMD)
Number of subjects: 56
Study 34757700 — intervention group
Group type: COMPARATOR
Intervention: Optional diet (OD)
Number of subjects: 56
Study 33557035 — intervention group
Group type: EXPERIMENTAL
Intervention: CE+HCO3 group (carbohydrate-electrolyte solution with bicarbonate)
Number of subjects: 16
Study 33557035 — intervention group
Group type: COMPARATOR
Intervention: TW group (tap water)
Number of subjects: 16
Study 34255812 — intervention group
Group type: EXPERIMENTAL
Intervention: Activating motor imagery (MI)
Number of subjects: 35
Study 34255812 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxing motor imagery (MI)
Number of subjects: 35
Study 34255812 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 35
Study 32540321 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative Dexamethasone (DEX) for 3 days
Number of subjects: 93
Study 32540321 — intervention group
Group type: COMPARATOR
Intervention: No Dexamethasone (NON-DEX)
Number of subjects: 93
Study 32304519 — intervention group
Group type: EXPERIMENTAL
Intervention: RPE (session rating of perceived exertion)
Number of subjects: 20
Study 32304519 — intervention group
Group type: COMPARATOR
Intervention: PP (predetermined progression method)
Number of subjects: 20
Study 32458501 — intervention group
Group type: EXPERIMENTAL
Intervention: Semisolid nutrients
Number of subjects: 5331
Study 32458501 — intervention group
Group type: COMPARATOR
Intervention: Liquid nutrients
Number of subjects: 5331
Study 32603172 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-qubit rotation gates
Number of subjects: 0
Study 32603172 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-qubit controlled-Z gate
Number of subjects: 0
Study 32603172 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-qubit geometric gates
Number of subjects: 0
Study 35455245 — intervention group
Group type: EXPERIMENTAL
Intervention: MF59-adjuvanted, H5N1 influenza pandemic vaccine (aH5N1c), two doses administered 21 days apart
Number of subjects: 3196
Study 35455245 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3196
Study 35455245 — intervention group
Group type: EXPERIMENTAL
Intervention: MF59-adjuvanted, H5N1 influenza pandemic vaccine (aH5N1c)
Number of subjects: 3196
Study 33158412 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinic-based recruitment
Number of subjects: 231
Study 33158412 — intervention group
Group type: EXPERIMENTAL
Intervention: Letters to patients from electronic databases
Number of subjects: 231
Study 33158412 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient portal
Number of subjects: 231
Study 33158412 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple recruitment strategies
Number of subjects: 231
Study 36158118 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved oral care method (oral scrubbing before intubation, brushing and washing after intubation, 3 times per day, using 0.1% povidone-iodine in oral care solution)
Number of subjects: 100
Study 36158118 — intervention group
Group type: COMPARATOR
Intervention: Routine oral care (scrubbing 3 times per day, using physiological brine)
Number of subjects: 100
Study 36158118 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved oral care method
Number of subjects: 100
Study 34374343 — intervention group
Group type: EXPERIMENTAL
Intervention: MATRIX score (age, height, smoking, renal failure, prior coronary artery bypass grafting, ST-segment elevation myocardial infarction, Killip class, radial expertise)
Number of subjects: 4197
Study 34374343 — intervention group
Group type: EXPERIMENTAL
Intervention: MATRIX score
Number of subjects: 4197
Study 33108925 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative sedation (midazolam)
Number of subjects: 125
Study 35603652 — intervention group
Group type: EXPERIMENTAL
Intervention: Xinfeng Capsule (XFC)
Number of subjects: 80
Study 35603652 — intervention group
Group type: COMPARATOR
Intervention: Leflunomide (LEF)
Number of subjects: 80
Study 33683315 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Navigation
Number of subjects: 0
Study 33683315 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 33472450 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorafenib
Number of subjects: 68
Study 33472450 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 68
Study 32517584 — intervention group
Group type: EXPERIMENTAL
Intervention: General Anesthesia (GA)
Number of subjects: 4429
Study 32517584 — intervention group
Group type: COMPARATOR
Intervention: Conscious Sedation (CS)
Number of subjects: 4429
Study 32517584 — intervention group
Group type: EXPERIMENTAL
Intervention: Local Anesthesia (LA)
Number of subjects: 4429
Study 36281767 — intervention group
Group type: EXPERIMENTAL
Intervention: Precuneus rTMS
Number of subjects: 50
Study 36281767 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 50
Study 615917865 — intervention group
Group type: EXPERIMENTAL
Intervention: ZCB00V
Number of subjects: 15
Study 615917865 — intervention group
Group type: COMPARATOR
Intervention: PY‐60AD
Number of subjects: 15
Study 33857238 — intervention group
Group type: EXPERIMENTAL
Intervention: Musical Improvisation (MI) group
Number of subjects: 0
Study 33857238 — intervention group
Group type: COMPARATOR
Intervention: Hands-Busy (HB) group
Number of subjects: 0
Study 36174746 — intervention group
Group type: EXPERIMENTAL
Intervention: MomMoodBooster2 program (eHealth group)
Number of subjects: 191
Study 36174746 — intervention group
Group type: COMPARATOR
Intervention: Routine care (routine-care group)
Number of subjects: 191
Study 32740293 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitions to failure (RF)
Number of subjects: 20
Study 32740293 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitions not to failure (NRF)
Number of subjects: 20
Study 32740293 — intervention group
Group type: COMPARATOR
Intervention: Non-exercise control (Con)
Number of subjects: 20
Study 32242973 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 0
Study 32242973 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 35945493 — intervention group
Group type: EXPERIMENTAL
Intervention: Care management intervention with a care manager, including 6 to 8 telephone contacts over 12 weeks
Number of subjects: 376
Study 35945493 — intervention group
Group type: EXPERIMENTAL
Intervention: Care management intervention
Number of subjects: 376
Study 35945493 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 376
Study 33732655 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal antibiotic usage
Number of subjects: 227
Study 33732655 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal probiotic usage
Number of subjects: 227
Study 33732655 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant probiotic intake
Number of subjects: 227
Study 33732655 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastmilk feeding
Number of subjects: 227
Study 33732655 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower socioeconomic status (SES)
Number of subjects: 227
Study 33732655 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital of birth
Number of subjects: 227
Study 32227774 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 70
Study 32227774 — intervention group
Group type: COMPARATOR
Intervention: Sham Acupressure
Number of subjects: 70
Study 36052499 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual therapy and common medication
Number of subjects: 24
Study 36052499 — intervention group
Group type: COMPARATOR
Intervention: Common medication only
Number of subjects: 24
Study 32338445 — intervention group
Group type: EXPERIMENTAL
Intervention: HOPE service (brief psychological therapy)
Number of subjects: 89
Study 33277507 — intervention group
Group type: EXPERIMENTAL
Intervention: tiotropium/olodaterol (5/5 µg) via Respimat® inhaler
Number of subjects: 3100
Study 33277507 — intervention group
Group type: COMPARATOR
Intervention: monocomponents via Respimat® inhaler
Number of subjects: 3100
Study 35189093 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg vaginal progesterone suppository nightly from 16 to 36 weeks of gestation
Number of subjects: 205
Study 35189093 — intervention group
Group type: COMPARATOR
Intervention: 250 mg intramuscular 17-hydroxyprogesterone caproate weekly from 16 to 36 weeks of gestation
Number of subjects: 205
Study 35189093 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg vaginal progesterone suppository nightly
Number of subjects: 205
Study 35189093 — intervention group
Group type: COMPARATOR
Intervention: 250 mg intramuscular 17-hydroxyprogesterone caproate weekly
Number of subjects: 205
Study 33559260 — intervention group
Group type: COMPARATOR
Intervention: Placebo inhalers (10 types including pMDI, Aerolizer, Handihaler, Turbohaler, Discus, Breezhaler, Ellipta, Easyhaler, Diskhaler, Respimat)
Number of subjects: 180
Study 33559260 — intervention group
Group type: EXPERIMENTAL
Intervention: Past-experience
Number of subjects: 180
Study 33559260 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaler-type
Number of subjects: 180
Study 33559260 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender
Number of subjects: 180
Study 33559260 — intervention group
Group type: EXPERIMENTAL
Intervention: Age category
Number of subjects: 180
Study 33559260 — intervention group
Group type: EXPERIMENTAL
Intervention: GOLD group
Number of subjects: 180
Study 32701012 — intervention group
Group type: EXPERIMENTAL
Intervention: OBG 8 times daily for 3 days, followed by 4 times daily for 11 days (Group 1)
Number of subjects: 45